MTHFR C677T polymorphism and recurrent early pregnancy loss risk in North Indian population

Reproductive Sciences

Volumn 19, Issue 2, 2012, Pages 210-215

  Nair, Rohini R ^a   Khanna, Anuradha ^b   Singh, Kiran ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

angiogenesis; C677T SNP; hyperhomocysteinemia; recurrent early pregnancy loss

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA;

ABORTION; ALLELE; ANGIOGENESIS; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENT EARLY PREGNANCY LOSS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; EMBRYO LOSS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INDIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY;

EID: 84859920094     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111417888     Document Type: Article

References (41)

1. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AIF, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update. 2003;9(2):163-174. (Pubitemid 36582604)
2. Extalo N. Early human nutrition. Eur J Obstet Gyn R B. 1995;61: 3-6.
3. Nelen WL, Bulten J, Steegers EA, Blom HJ, Hanselaar AG, Eskes TK.Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000;15(4):954-960. (Pubitemid 30192752)
4. Choi HK, Choi BC, Lee SH, Kim JW, Cha KY, Baek KH. Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy patients. Mol Reprod Dev. 2003;66(1):24-31. (Pubitemid 36927783)
5. Bailey L, Gregory J. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr. 1999;129(5):919-922. (Pubitemid 29214439)
6. Wenstrom K, Johanning G, Owen J, et al. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites. Am J Med Genet. 2000; 90(1):6-11. (Pubitemid 30010822)
7. Wang J, Trudinger B, Duarte N, Wilcken D, Wang X. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia. BJOG. 2000;107(7):935-938. (Pubitemid 30417353)
8. Ray J, Laskin C. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta. 1999;20(7):519-529. (Pubitemid 29391295)
9. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and preecla psia. J Med Genet. 1997;34(6):525-526. (Pubitemid 27268138)
10. McCully K.Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism. Ann Clin Lab Sci. 1994;24(1):27-59. (Pubitemid 24054066)
11. Wouters MG, Boers GH, Blom HJ, et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril. 1993;60(5):820-825.
12. Cai D, Ning L, Pan C, et al. Association of polymorphisms in folate metabolic genes and prostate Cancer risk: a case-control study in a Chinese population. J Genet. 2010;89(2):263-267.
13. Obwegeser R, Sinzinger HM. Homocysteine-a pathophysiological cornerstone in obstetrical and gynaecological disorders? Hum Reprod Update. 1999;5(1):64-72. (Pubitemid 29142275)
14. Frosst P, Blom H, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-113.
15. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol.Genet Metab. 1998;64(3):169-172. (Pubitemid 28453294)
16. Mostowska A, Hozyasz KK, Wojcicki P, Dziegelewska M, Jagodzinski PP. Associations of folate and choline metabolism gene polymorphisms with orofacial clefts. J Med Genet. 2009; 47(12):809-815. DOI: 10.1136/jmg.2009.070029.
17. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149-1160.
18. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175-191.
19. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb. 1993;13(9):1327-1333. (Pubitemid 23271135)
20. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001;103(22):2717-2723. (Pubitemid 32538788)
21. Hefler L, Jirecek S, Heim K, et al. Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study. J Soc Gynecol Investig. 2004;11(1):42-44. (Pubitemid 38050190)
22. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361(9361):901-908. (Pubitemid 36335814)
23. Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol. 2005;105(1):182-192. (Pubitemid 40189930)
24. Tempfer C, Schneeberger C, Riener EK, Hefler LA, Keck C. Polymorphisms for risk assessment of pregnancy-associated disorders: review of the literature and meta-analysis. Geburtsh Frauenheilk. 2004;64(10):1080-1089. (Pubitemid 39457847)
25. Van der Molen EF, Arends GE, Nelen WL, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol. 2000;182(5):1258-1263. (Pubitemid 30353321)
26. Unfried G, Griesmacher A, Weismuller W, Nagele F, Huber JC, Tempfer CB. The C677T polymorphism of the methylenetetrahydrofolate reductase gene and idiopathic recurrent miscarriage. Obstet Gynecol. 2002;99(4):614-619. (Pubitemid 34246300)
27. Nelen WL, Steegers EA, Eskes TK, Blom HJ. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet. 1997; 350(9081):861. (Pubitemid 27404349)
28. Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris JC. A woman with five consecutive fetal deaths: case report and retrospective analysis of hyperhomocysteinaemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril. 1998;69(1):152-154. (Pubitemid 28073011)
29. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril. 2002;77(2):342-347. (Pubitemid 34086913)
30. Foka ZJ, Lambropoulos AF, Saravelos H, et al. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod. 2000;15(2):458-462. (Pubitemid 30076732)
31. Makino A, Nakanishi T, Sugiura-Ogasawara M, Ozaki Y, Suzumori N, Suzumori K. No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss. Am J Reprod Immunol. 2004;52(1):60-66. (Pubitemid 39023024)
32. Kutteh WH, Park VM, Deitcher SR. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril. 1999;71(6):1048-1053. (Pubitemid 29252494)
33. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002;17(6):1633-1637. (Pubitemid 34661820)
34. Biswas A, Choudhry P, Mittal A, et al. Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism. Clin Appl Thromb Hemost. 2008;4(1):102-104.
35. Mukhopadhyay R, Saraswathy KN, Ghosh PK. MTHFR C677T and factor V Leiden in recurrent pregnancy loss: a study among an endogamous group in north India. Genet Test Mol Biomarkers. 2009;13(6):861-865.
36. Kumar KSD, Govindaiah V, Naushad SE, Devi RR, Jyothy A. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynecol. 2003;23(1):55-58. (Pubitemid 36169553)
37. Lakshmi AV, Maniprabha C, Krishna TP. Plasma homocysteine level in relation to folate and vitamin B6 status in apparently normal men. Asia Pac J Clin Nutr. 2001;10(3):194-196. (Pubitemid 33739354)
38. Refsum M, Yajnik CS, Gadkari M, et al. Hyperhomocysteinaemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr. 2001; 74(2):233-241. (Pubitemid 32702491)
39. Singh K, Singh SK, Sah R, Singh I, Raman R. Mutation C677T in the methylenetetrahydrofolate reductase gene is associated with male infertility in an Indian population. Int J Androl. 2005; 28(2):115-119. (Pubitemid 40461182)
40. Habibzadeh N, Schorah CJ, Smithells RW. The effects of maternal folic acid and vitamin C nutrition in early pregnancy on reproductive performance in the guinea-pig. Br J Nutr. 1986;55(1): 23-35. (Pubitemid 16180192)
41. Tremblay GF, Matte JJ, Dufour JJ, Brisson GJ. Survival rate and development of fetuses during the first 30 days of gestation after folic acid addition to a swine diet. J Anim Sci. 1989;67(3): 724-732.